Neurons expressing metabotropic glutamate receptor 2 (mGluR2), also known as GRM2, are a critical component of the glutamatergic system in the brain. mGluR2 belongs to Group II metabotropic glutamate receptors (along with mGluR3/GRM3), which are primarily located on presynaptic terminals and regulate neurotransmitter release [1]. These neurons play essential roles in modulating excitatory transmission, anxiety regulation, neuroprotection, and various cognitive processes. The mGluR2 system has emerged as an important therapeutic target for neurological and psychiatric disorders.
The GRM2 gene is located on chromosome 7q21.12 in humans and encodes a 872-amino acid protein [2]. mGluR2 is a class C G-protein coupled receptor with distinct structural features:
Receptor Structure:
mGluR2 belongs to Group II mGluRs:
mGluR2 activates Gi/o protein signaling:
mGluR2-expressing neurons are found throughout the CNS:
| Brain Region | Expression Level | Function |
|---|---|---|
| Cortex | High | Modulation of excitation |
| Hippocampus | High | Memory, learning |
| Amygdala | High | Anxiety regulation |
| Basal Ganglia | Moderate | Motor control |
| Thalamus | Moderate | Sensory processing |
| Cerebellum | Low | Motor learning |
mGluR2 is predominantly presynaptic:
mGluR2 is an autoreceptor that regulates glutamate release:
Negative Feedback:
Modulation:
mGluR2 in the amygdala regulates anxiety:
Anxiolytic Effects:
Mechanisms:
mGluR2 activation can be neuroprotective:
In the hippocampus:
mGluR2 is a potential therapeutic target in Alzheimer's disease:
Dysregulation:
Therapeutic Potential:
mGluR2 is strongly implicated in schizophrenia:
Evidence:
Therapeutic Development:
mGluR2 may be affected in ALS:
Clinical Candidates:
Mechanism:
Development:
Potential Uses:
Niswender, C.M., & Conn, P.J. (2010). Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annual Review of Pharmacology and Toxicology, 50, 295-322 ↩︎
Linden, A.M., et al. (2005). Anxiolytic-like action of the mGluR2/3 agonist LY379268. Neuropharmacology, 49(S1), 220 ↩︎
Dwyer, J.M., et al. (2012). Group II metabotropic glutamate receptors in Alzheimer's disease. Neuropharmacology, 62(5-6), 2128-2137 ↩︎